UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females

European Journal of Clinical Pharmacology

Volumn 62, Issue 10, 2006, Pages 829-837

  Mercke Odeberg, J ^a   Andrade, J ^b   Holmberg, K ^b   Hoglund, P ^a   Malmqvist, U ^a   Odeberg, J ^b,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bilirubin; Haplotype; Human diversity panel; Linkage disequilibrium; Polymorphism; Sex; UGT1A gene

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A7; ISOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME SUBSTRATE; ETHNOLOGY; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCURONIDATION; HAPLOTYPE; HOMOZYGOSITY; HUMAN; MALE; NORMAL HUMAN; PHARMACOGENETICS; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEX DIFFERENTIATION; SWEDEN;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BILIRUBIN; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; ISOENZYMES; LINKAGE DISEQUILIBRIUM; MALE; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; SEX FACTORS; SWEDEN; VARIATION (GENETICS);

EID: 33749487917     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0166-3     Document Type: Article

References (30)

1. Evans WE, McLeod HL (2003) Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 348:538-549
2. Meisel C, Gerloff T, Kirchheiner J, Mrozikiewicz PM, Niewinski P, Brockmoller J, Roots I (2003) Implications of pharmacogenetics for individualizing drug treatment and for study design. J Mol Med 81:154-167
3. Miners JO, McKinnon RA, Mackenzie PI (2002) Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology 181-182:453-456
4. Bosma PJ (2003) Inherited disorders of bilirubin metabolism. J Hepatol 38:107-117
5. Kiang TK, Ensom MH, Chang TK (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106:97-132
6. Chowdhury JR, Chowdhury NR, Jansen PLM (2003) Bilirubin metabolism and its disorders in hepatology. In: Zakim D, Boyer TD (eds) Hepatology: a textbook of liver disease, 4th edn. Saunders, Philadelphia, pp 233-270
7. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171-1175
8. Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y (2000) Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60:6921-6926
9. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
10. Holmberg K, Persson ML, Uhlen M, Odeberg J (2005) Pyrosequencing analysis of thrombosis-associated risk markers. Clin Chem 51:1549-1552
11. Odeberg J, Holmberg K, Eriksson P, Uhlen M (2002) Molecular haplotyping by pyrosequencing. Biotechniques 33:1104, 1106, 1108
12. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989
13. Excoffier L, Slatkin M (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927
14. Devlin B, Risch N (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311-322
15. Abecasis GR, Cookson WO (2000) GOLD-graphical overview of linkage disequilibrium. Bioinformatics 16:182-183
16. Fitch WM, Margoliash E (1967) Construction of phylogenetic trees. Science 155:279-284
17. Beutler E, Gelbart T, Demina A (1998) Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95:8170-8174
18. Kohle C, Mohrle B, Munzel PA, Schwab M, Wernet D, Badary OA Bock KW (2003) Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP- glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol 65:1521-1527
19. Lampe JW, Bigler J, Horner NK, Potter JD (1999) UDP- glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 9:341-349
20. Ando Y, Chida M, Nakayama K, Saka H, Kamataki T (1998) The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics 8:357-360
21. Ciotti M, Marrone A, Potter C, Owens IS (1997) Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7:485-495
22. Peters WH, te Morsche RH, Roelofs HM (2003) Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome. J Hepatol 38:3-8
23. Burchell B, Hume R (1999) Molecular genetic basis of Gilbert's syndrome. J Gastroenterol Hepatol 14:960-966
24. Fever JP, Blanckaert N (1991) Hyperbilirubinaemia. In: McIntyre N, Benhamou J, Bircher J et al. (eds) Oxford textbook of clinical hepatology. Oxford University Press, Oxford, pp 985-991
25. Manolio TA, Burke GL, Savage PJ, Jacobs DR Jr, Sidney S, Wagenknecht LE, Allman RM, Tracy RP (1992) Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem 38:1853-1859
26. Rosenthal P, Pincus M, Fink D (1984) Sex- and age-related differences in bilirubin concentrations in serum. Clin Chem 30:1380-1382
27. Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M, Karrison T, Janisch L, Ramirez J, Rudin CM, Vokes EE, Ratain MJ (2004) Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 22:1382-1388
28. Strassburg CP, Oldhafer K, Manns MP, Tukey RH (1997) Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 52:212-220
29. Gagne JF, Montminy V, Belanger P, Journault K, Gaucher G, Guillemette C (2002) Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 62:608-617
30. Hanioka N, Ozawa S, Jinno H, Ando M, Saito Y, Sawada J (2001) Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin. Xenobiotica 31:687-699